Publication Date:
1993-10-01
Description:
The pathogenic human parvovirus B19 replicates only in erythroid progenitor cells. This virus was shown to bind to blood-group P antigen, as measured by hemagglutination. Erythrocytes lacking P antigen were not agglutinated with B19. Purified P antigen (globoside) blocked the binding of the virus to erythroid cells and the infectivity of the virus in a hematopoietic colony assay. Target cells were protected from infection by preincubation with monoclonal antibody to globoside. Knowledge of a parvovirus receptor has implications for understanding the pathogenesis of parvovirus infections and for the use of parvoviruses in gene therapy.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Brown, K E -- Anderson, S M -- Young, N S -- New York, N.Y. -- Science. 1993 Oct 1;262(5130):114-7.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD 20892.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/8211117" target="_blank"〉PubMed〈/a〉
Keywords:
Antibodies, Monoclonal
;
Capsid/metabolism
;
Carbohydrate Sequence
;
Cytopathogenic Effect, Viral
;
Erythrocyte Membrane/immunology/*microbiology
;
Erythroid Precursor Cells/cytology/microbiology
;
Globosides/immunology/*metabolism/pharmacology
;
Hemagglutination
;
Humans
;
Molecular Sequence Data
;
P Blood-Group System/immunology/*metabolism
;
Parvovirus B19, Human/immunology/*metabolism/physiology
;
Phenotype
;
Receptors, Virus/*metabolism
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink